0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Medical News and Perspectives |  May 08, 2013
The Cochrane Collaboration Turns 20:  Assessing the Evidence to Inform Clinical Care
M. J. Friedrich
JAMA. 2013;309(18):1881-1882. doi:10.1001/jama.2013.1827.
Viewpoint |  April 03, 2013 FREE
Ushering in a New Era of Open Science Through Data Sharing:  The Wall Must Come Down
Joseph S. Ross, MD, MHS; Harlan M. Krumholz, MD, SM
JAMA. 2013;309(13):1355-1356. doi:10.1001/jama.2013.1299.
Editorial |  March 27, 2013 FREE
Concerns About Reliability in the Trial to Assess Chelation Therapy (TACT)
Steven E. Nissen, MD
JAMA. 2013;309(12):1293-1294. doi:10.1001/jama.2013.2778.
Editorial |  March 27, 2013 FREE
Evaluation of the Trial to Assess Chelation Therapy (TACT):  The Scientific Process, Peer Review, and Editorial Scrutiny
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA; Robert M. Golub, MD
JAMA. 2013;309(12):1291-1292. doi:10.1001/jama.2013.2761.
INCLUDES: , Supplemental Content
Editorial |  March 13, 2013 FREE
Thank You to JAMA Peer Reviewers and Authors
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2013;309(10):1034. doi:10.1001/jama.2013.1885.
Editorial |  March 06, 2013
The JAMA Network Reader:  A New Web App for JAMA and the JAMA Network Journals
Howard Bauchner, MD; Matt Herron; Paul Gee; et al.
JAMA. 2013;309(9):928. doi:10.1001/jama.2013.1225.
Special Communication |  February 27, 2013 FREE
Reporting of Patient-Reported Outcomes in Randomized Trials:  The CONSORT PRO Extension
Melanie Calvert, PhD; Jane Blazeby, MD; Douglas G. Altman, DSc; et al.
JAMA. 2013;309(8):814-822. doi:10.1001/jama.2013.879.
INCLUDES: , Supplemental Content
Editorial |  February 13, 2013 FREE
Restoring Confidence in the Pharmaceutical Industry
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2013;309(6):607-609. doi:10.1001/jama.2013.58.
Editorial |  February 06, 2013
The Restructuring of Structured Abstracts:  Adding a Table in the Results Section
Howard Bauchner, MD; Ronna Henry, MD; Robert M. Golub, MD
JAMA. 2013;309(5):491-492. doi:10.1001/jama.2013.76.
Editorial |  January 02, 2013 FREE
Introducing JAMA Clinical Evidence Synopsis:  From Systematic Reviews to Clinical Practice
Mary McGrae McDermott, MD; Edward H. Livingston, MD
JAMA. 2013;309(1):89. doi:10.1001/jama.2012.148063.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Research Letters  |  May 27, 2013
Ghostwriting Policies in High-Impact Biomedical Journals: A Cross-Sectional Study
Xavier Bosch, MD, PhD; Cristina Hernández, MD; Juan M. Pericas, MD; et al.
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Time to Publication Among Completed Clinical Trials
Joseph S. Ross, MD, MHS; Marian Mocanu, MD; Julianna F. Lampropulos, MD; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Invited Commentary  |  March 25, 2013
Biomarkers in Cardiovascular Medicine:  The Shame of Publication Bias
Comment on “Bias in Associations of Emerging Biomarkers With Cardiovascular Disease”
Steven E. Nissen, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems